Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,090
Total Claims
$1.1M
Drug Cost
741
Beneficiaries
$1,476
Cost/Patient
Risk Score Breakdown 54/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+1357%
Opioid rate vs peers
55.1% vs 3.8% avg
+26%
Cost per patient vs peers
$1,476 vs $1,174 avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid prescribing rate is 1,357% above the average for Nurse Practitioner providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Composite risk score of 54/100 places this provider in the "High Risk" category — the top 0.017% of all Medicare Part D prescribers. Multiple independent risk factors are contributing simultaneously.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
55.1%
Opioid Rate
4,457
Opioid Claims
$577K
Opioid Cost
18.4%
Long-Acting Rate
This provider's opioid prescribing rate of 55.1% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 7,164 claims · $320K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Abaloparatide | 32 | $94K |
| Tapentadol Hcl | 73 | $81K |
| Oxycodone Hcl | 75 | $70K |
| Oxycodone Myristate | 57 | $68K |
| Oxycodone Hcl/Acetaminophen | 984 | $52K |
| Buprenorphine Hcl | 56 | $51K |
| Methylnaltrexone Bromide | 21 | $51K |
| Tapentadol Hcl | 28 | $50K |
| Ubrogepant | 31 | $50K |
| Hydrocodone/Acetaminophen | 1,354 | $49K |
| Naloxegol Oxalate | 73 | $31K |
| Rimegepant Sulfate | 27 | $29K |
| Pregabalin | 418 | $29K |
| Buprenorphine | 90 | $28K |
| Fentanyl | 143 | $26K |
Prescribing Profile
62
Unique Drugs
54.0
Anomaly Score
Patient Profile
65
Avg Age
59%
Female
1.78
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data